Shares of Apogee Therapeutics Inc. (APGE) have gained 41.4% over the past four weeks to close the last trading session at $55.7, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $94.3 indicates a potential upside of 69.3%.The mean estimate comprises 10 short-term price targets with a standard deviation of $16.3. While the lowest estimate of $60.00 indicates a 7.7% increase from t ...

Shares of Ocular Therapeutix (OCUL) have gained 4% over the past four weeks to close the last trading session at $11.48, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $21 indicates a potential upside of 82.9%.The mean estimate comprises 12 short-term price targets with a standard deviation of $4.92. While the lowest estimate of $14.00 indicates a 22% increase from the current ...

Shares of Oruka Therapeutics, Inc. (ORKA) have gained 42.7% over the past four weeks to close the last trading session at $27.44, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $44.89 indicates a potential upside of 63.6%.The average comprises nine short-term price targets ranging from a low of $26.00 to a high of $60.00, with a standard deviation of $9.82. While the lowest est ...

Shares of Tamboran Resources Corporation (TBN) have gained 25.8% over the past four weeks to close the last trading session at $26.61, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $38 indicates a potential upside of 42.8%.The average comprises five short-term price targets ranging from a low of $32.00 to a high of $42.00, with a standard deviation of $3.94. While the lowest e ...

Shares of Amylyx Pharmaceuticals, Inc. (AMLX) have gained 3.6% over the past four weeks to close the last trading session at $14.31, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.5 indicates a potential upside of 29.3%.The mean estimate comprises eight short-term price targets with a standard deviation of $3.85. While the lowest estimate of $12.00 indicates a 16.1% decline ...

Cognizant (CTSH) closed the last trading session at $68.03, gaining 2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $85.5 indicates a 25.7% upside potential.The mean estimate comprises 20 short-term price targets with a standard deviation of $8.79. While the lowest estimate of $70.00 indicates a 2.9% increase from the current price level, the most optimistic analyst expects the ...

Shares of Dutch Bros (BROS) have gained 7.1% over the past four weeks to close the last trading session at $57.14, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $79.38 indicates a potential upside of 38.9%.The mean estimate comprises 16 short-term price targets with a standard deviation of $8.48. While the lowest estimate of $65.00 indicates a 13.8% increase from the current p ...

Orla Mining Ltd. (ORLA) closed the last trading session at $10.95, gaining 4.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $16.31 indicates a 49% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $2.98. While the lowest estimate of $12.89 indicates a 17.7% increase from the current price level, the most optimistic analyst ...

Shares of Elastic (ESTC) have gained 0.2% over the past four weeks to close the last trading session at $86.07, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $118.33 indicates a potential upside of 37.5%.The mean estimate comprises 24 short-term price targets with a standard deviation of $15.52. While the lowest estimate of $90.00 indicates a 4.6% increase from the current pri ...

Castle Biosciences, Inc. (CSTL) closed the last trading session at $23.74, gaining 4.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $35.63 indicates a 50.1% upside potential.The average comprises eight short-term price targets ranging from a low of $30.00 to a high of $41.00, with a standard deviation of $3.54. While the lowest estimate indicates an increase of 26.4% from the c ...